Two area biotechs raise $210 in IPOs, then watch shares soar

Cambridge-based Solid Biosciences and Boston-based resTORbio raised a combined $210 million in initial public offerings over the past day, and as of 3 p.m. both the company’s shares were trading significantly up from the IPO price.